Robert Huddart, professor, The Institute of Cancer Research, discusses the HYBRID trial which assessed hypofractionated bladder radiotherapy with or without image guided adaptive planning in elderly patients with bladder cancer.
Robert Huddart
Articles by Robert Huddart
Latest Updated Articles
An Overview of the HYBRID Study in Elderly Patients With Bladder CancerPublished: March 6th 2017 | Updated: